2017 APSR Congress
Scientific Programme
Sunday 26 November 2017
- 08:30 - 10:00
Clinical Respiratory Medicine: Clinical cases
Room: Cockle Bay 1- 08:30 - 08:50
Doctor, my back is so painful
Speaker: Thomas Mok, Hong Kong - 08:50 - 09:05
Singing myself awake
Speaker: Thomas Mok, Hong Kong - 09:05 - 09:25
Survival creates novel challenges
Speaker: Thomas Mok, Hong Kong - 09:25 - 09:50
Put away the binoculars
Speaker: Thomas Mok, Hong Kong - 09:50 - 10:00
Spot diagnosis
Speaker: Thomas Mok, Hong Kong
- 08:30 - 08:50
COPD 2: Predicting progression and therapeutic responses in COPD
Room: Darling Harbour Theatre- 08:30 - 09:00
Cells and cytokines
Speaker: Ian Yang, AU - 09:00 - 09:30
Airway and lung imaging
Speaker: Greg King, AU - 09:30 - 10:00
Clinical markers
Speaker: Alberto Papi, Italy
- 08:30 - 09:00
This program currently is under development and is subject to change Interstitial Lung Disease 2: Improving diagnosis and treatment of NSIP
Room: Cockle Bay 2- 08:30 - 09:10
Mini-MDT - diagnosis/imaging
Speaker: Michael Jones, Wendy Cooper & Lauren Troy, NSW - 09:10 - 09:35
When steroids are not working; second line therapies for NSIP
Speaker: Margaret Wilsher, NZ - 09:35 - 10:00
Emerging understanding of NSIP
Speaker: Takafumi Suda, Japan
- 08:30 - 09:10
Oral Presentations: Asthma 2
Room: E3.1- 08:30 - 08:40
Ghrelin Protects against Airway Eosinophilic Inflammation in Asthma
Speaker: Hironobu Tsubouchi, Japan - 08:40 - 08:50
Obesity, Defined by Body Mass Index of no Less than 25 kg/m2, is a Risk Factor for Poor Asthma Control in East-Asian Female Populations
Speaker: Masako To, Japan - 08:50 - 09:00
Free Fatty Acid Receptors 1 and 4 are Novel Bronchodilator Targets for Asthma
Speaker: Ralph Angeles, AU - 09:00 - 09:10
Associations between Nutrient-Based Dietary Patterns and Lung Function in Middle-Aged and Older Australian Adults
Speaker: Stephanie Byrne, AU - 09:10 - 09:20
Analysis of T Cell-Induced Bronchoconstriction in Murine Asthma Model
Speaker: Akio Mori, Japan - 09:20 - 09:30
Enzyme Markers of Neutrophilic Segment of Bronchial Inflammation at Osmotic Airway Hyperresponsiveness in Patients with Asthma
Speaker: Juliy Perelman, Russia - 09:30 - 09:40
Effects of the Addition of Tiotropium Versus Montelukast on Airway Inflammation and Remodeling in Symptomatic Asthma
Speaker: Makoto Hoshino, Japan - 09:40 - 09:50
Therapeutic Effects of Histone Deacetylase Enzyme 8 Inhibitors (HDAC8I) in a Murine Asthma Model
Speaker: Yuan Ren, China
- 08:30 - 08:40
Oral Presentations: Critical Care Medicine
Room: E3.2- 08:30 - 08:45
Clinical Difference Between Direct and Indirect Causes of Acute Respiratory Distress
Syndrome: A Retrospective Cohort Study of 216 Patients
Speaker: Keisuke Anan, Japan - 08:45 - 08:55
Efficacy of Continuous Blood Purification on Patients with Severe Acute Pancreatitis Associated Acute Respiratory Distress Syndrome
Speaker: Feihu Zhou, China - 08:55 - 09:10
Ventilatory Dyssynchrony in Mechanically Ventilated Patients: Is it a Problem?
Speaker: Peter Sottile, US - 09:10 - 09:20
Efficacy and Safety of Acetazolamide for Hypercapnic Respiratory Failure Associated with Metabolic Alkalosis in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Trials
Speaker: Carla Emille Barbon, Philippines - 09:20 - 09:30
The Role of CIAP2 in Avian Influenza A (H7N9) Induced Acute Lung Injury Through Inducing RIPK1/3 -Dependent Necroptosis
Speaker: Chu Qin, China - 09:30 - 09:40
Induced Pluripotent Stem Cells Prevent Endothelial Cell Leakage via TIMP-1 to Reduce Fak/Snail Pathway in Sepsis-Induced Acute Lung Injury
Speaker: Vincent Yi-Fong Su, Taiwan - 09:40 - 09:50
MIR-34B-5P Inhibition Alleviates Inflammatory Response and Apoptosis via Targeting Progranulin in Acute Lung Injury Induced by Lipopolysaccharide
Speaker: Zhongliang Guo, China - 09:50 - 10:00
Pleural Research in Intensive Care (Prince-1) a Prospective Observational Study of Pleural Effusion Management
Speaker: Portia Smallbone, AU
- 08:30 - 08:45
Oral Presentations: Lung Cancer 2
Room: E3.4- 08:30 - 08:40
Examination of the Rate of Quitting to Smoke among Smoker Patients who Underwent Lung Cancer Operation
Speaker: Takaharu Kiribayashi, Japan - 08:40 - 08:50
Update from the Lungscreen WA Project - a Feasability Study of Low-Dose CT Lung Cancer Screening of High-Risk Ever Smokers in Australia
Speaker: Kuan Pin Lim, AU - 08:50 - 09:00
Protocol for the International Lung Screen Trial (ILST): A Cohort Study to Define LDCT Screening Selection Criteria and Validate the Pancan Nodule Management Algorithm
Speaker: Kuan Pin Lim, AU - 09:00 - 09:10
Prediction Modeling using Routine Clinical Parameters to Stratify Survival in Mesothelioma Patients Undergoing Surgery
Speaker: Edward Harris, AU - 09:10 - 09:20
Lung Cancer in the Eastern Part of Libya
Speaker: Khalid A Gaber, Libya - 09:20 - 09:30
A Rare Case of Concomitant Medullary Thymoma with Multidrug-Resistant
Tuberculosis
Speaker: Achmad Gozali, Indonesia - 09:30 - 09:40
Combined use of a Laryngeal Mask Airway During Extubation Reduces the Incidence of Postoperative Pulmonary Fistula in Patients Undergoing Lung Cancer Surgery
Speaker: Hikaru Watanabe, Japan - 09:40 - 09:50
Comparison of Re-Biopsy Successful Rate among Procedures and Sequential Change of EBUS Image
Speaker: Kei Morikawa, Japan
- 08:30 - 08:40
Oral Presentations: Tuberculosis 3
Room: E3.10- 08:30 - 08:40
A Cluster Randomised Controlled Trial of Contact Investigation for the Detection of Tuberculosis: The Act2 Trial
Speaker: Greg Fox, AU - 08:40 - 08:50
High Prevalence of Latent Tuberculosis Infection among Healthcare Workers with History of Contact with Tuberculosis Patient in High Burden Tuberculosis Hospital
Speaker: Rinaldy Lubis, Indonesia - 08:50 - 09:00
Tuberculosis Disease among Healthcare Workers: Clinical Characteristics, Drug Resistance and Treatment Outcomes in Chiang Mai University Hospital, Thailand
Speaker: Juthamas Inchai, Thailand - 09:00 - 09:10
Treatment Outcomes of MDR-TB and Referral Networks in an Out-Patient Private-Initiated Programmatic Management for Drug Resistant Tuberculosis (PMDT) Facility
Speaker: Victoria Dalay, Philippines - 09:10 - 09:20
To Assess Treatment Outcome of Multidrug Resistant Tuberculosis in Japan - analysis of Japan TB Surveillance Data
Speaker: Lisa Kawatsu, Japan - 09:20 - 09:30
Analysis of Treatment Duration for Multidrug Resistant Tuberculsis Patients in Japan
Speaker: Kazuhiro Uchimura, Japan - 09:30 - 09:40
Multidrug-Resistant Tuberculosis Treatment Outcome: Tertiary Center Experience
Speaker: Syazatul Syakirin Sirol Aflah, Malaysia - 09:40 - 09:50
Relapse of Tuberculosis among Patients Completing Treatment in Vietnam: A Nested Case-Control Study
Speaker: Jessica Bestrashniy, AU - 09:50 - 10:00
Study of Diagnostic Utility of Xpert MTB/RIF Test on Pleural Fluid in the Evaluation of Patients Presenting with Pleural Tuberculosis in Nepal
Speaker: Deebya Raj Mishra, Nepal
- 08:30 - 08:40
- 10:00 - 10:30
Morning Tea and Exhibition Viewing
Room: Exhibition Hall - 10:30 - 11:30
Plenary: Memorial Lecture: Michiyoshi Harasawa Research Award
Room: Darling Harbour Theatre- 10:30 - 10:35
Introduction
- 10:35 - 11:20
Respiratory research using cellular, molecular and physiologic approaches Speaker: Takahide Nagase, Japan
- 11:20 - 11:30
Award presentation
- 10:30 - 10:35
- 11:30 - 13:00
Asthma 2: Obesity, diet and asthma
Room: Darling Harbour Theatre- 11:30 - 12:00
Asthma, health literacy and Maori
Speaker: Tristram Ingham, NZ - 12:00 - 12:30
Obesity in severe asthma - cause or co-morbidity?
Speaker: Celeste Porsbjerg, Denmark - 12:30 - 13:00
Obesity and asthma: Investigating the roles of diet, exercise and adiposity
Speaker: Hayley Scott, AU
- 11:30 - 12:00
Critical Care 2: Managing Multiple Organ Dysfunction Syndrome
Room: Cockle Bay 2- 11:30 - 11:55
Using ultrasound to optimise fluid management in MODS
Speaker: Suthaporn Lumlertgul, Thailand - 11:55 - 12:20
Optimal management of nutrition acutely and in recovery
Speaker: Hayden White, AU - 12:20 - 12:45
Muscle wasting and weakness in ICU: causes, mitigation, management
Speaker: Linda Denehy, AU - 12:45 - 13:00
Optimising post-ICU rehabilitation
Speaker: Marc Moss, US
- 11:30 - 11:55
Tuberculosis: Drug-resistant TB
Room: Cockle Bay 1- 11:30 - 12:00
Impact assessment of the roll-out of new TB diagnostics
Speaker: Charles Yu, Philippines - 12:00 - 12:30
MDR TB new TB regimens
Speaker: Erlina Burhan, Indonesia - 12:30 - 13:00
Systems solutions to resistance development
Speaker: Greg Fox, AU
- 11:30 - 12:00
Oral Presentations: Late Breaking
Room: E3.1- 11:30 - 11:40
Airway Closure and Rate of Derecruitment Measured by the Forced Oscillation Technique is Elevated in Subjects with Asthma
Speaker: Kris Nilsen, AU - 11:40 - 11:50
Forced Oscillation Technique as a Predictor of Exercise Tolerance in COPD
Speaker: Akito Yamamoto, Japan - 11:50 - 12:00
Assessing Direct Switch to Indacaterol/Glycopyrronium from Salmeterol/Fluticasone in Moderate to Severe Symptomatic COPD Patients: The Flash Study
Speaker: Dina Diaz, Philippines - 12:00 - 12:10
A Novel Quantitative-CT/ FEV1 Approach of Phenotyping COPD to Predict Mortality
Speaker: Li Cher Loh, Malaysia - 12:10 - 12:20
Respect-Meso: An International Multicentre non-Blinded Randomized Controlled Trial to Assess the Impact of Regular Early Specialist Palliative Care in Malignant Pleural Mesothelioma
Speaker: Fraser Brims, AU - 12:20 - 12:30
Prevalence and Comorbidities of Obstructive Sleep Apnoea in the Busselton Healthy Ageing Study (BHAS)
Speaker: Jordan Cunningham, AU
- 11:30 - 11:40
Oral Presentations: Lung Cancer 3
Room: E3.10- 11:30 - 11:40
Common and Uncommon EGFR Mutations Analysis in Cytology and Plasma Samples of Treatment-Naive Lung Cancer Patients
Speaker: Ahmad Utomo, Indonesia - 11:40 - 11:50
Kras Mutation in EGFR Wild Type Indonesian Lung Cancer Patient
Speaker: Najmiatul Masykura, Indonesia - 11:50 - 12:05
Risk in High-Risk Populations: Moving CT Screening Beyond the Search for a Potential Lung Cancer
Speaker: Matthew Kinsey, US - 12:05 - 12:15
Importance of the Preoperative Neutrophil/Lymphocyte Ratio and Prognostic Nutritional Index for Pathological-Stage I Lung Cancer Patients
Speaker: Isamu Watanabe, Japan - 12:15 - 12:25
Serum CEA And CYFRA Responses as Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients
Speaker: Akihiro Yoshimura, Japan - 12:25 - 12:35
PD-L1 TPS Analysis in Real-World Clinical Practice: Evaluation of Specimens Obtained by Respiratory Endoscopic Biopsy
Speaker: Midori Tanaka, Japan - 12:35 - 12:50
The Efficacy and Safety of Carboplatin and Weekly Paclitaxel Combination Therapy for Previously Treated Small Cell Lung Cancer Patients with Interstitial Lung Disease
Speaker: Ryo Itotani, Japan
- 11:30 - 11:40
Oral Presentations: Pulmonary Circulation
Room: E3.4- 11:30 - 11:40
Two Cases of Pulmonary Hypertension Associated with Chronic Myeloproliferative Disorders
Speaker: Minoru Inomata, Japan - 11:40 - 11:50
TNF-A Increases Vasoreactivity of Intrapulmonary Arteries in Mouse Precision Cut Lung Slices
Speaker: Emma Lamanna, AU - 11:50 - 12:00
Dynamic Changes of Macrophage M1/M2 Polarization in Monocrotaline-Induced Pulmonary Arterial Hypertension
Speaker: Yong Fan, China - 12:00 - 12:10
Bio-Distribution of EPCS in Disease and the Potential Role of Exosomes in Cell Therapy for Pulmonary Vascular Diseases
Speaker: Rebecca Harper, AU - 12:10 - 12:20
Real-Life Versus Clinical Trial Patients in Pulmonary Arterial Hypertension: An Analysis from the PHSANZ Registry
Speaker: Nicole Roche, AU - 12:20 - 12:30
Outcomes of Idiopathic Pulmonary Arterial Hypertension in the Era of Combination Therapy: A Report from the PHSANZ Registry
Speaker: Jamal Al-Aghbari, AU - 12:30 - 12:40
Long-Term Follow-Up in Serum Brain Natriuretic Peptide after Pulmonary Lobectomy for Lung Cancer
Speaker: Mitsuhiro Kamiyoshihara, Japan - 12:40 - 12:55
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as predictive markers for DVT
Speaker: Jason Mouabbi, US
- 11:30 - 11:40
Poster Session
Room: Exhibition Hall- 13:00 - 14:00
Lunch and Exhibition Viewing
Room: Exhibition Hall- 14:00 - 15:30
Bronchoscopy and Interventional Techniques 2: Applications of cryobiopsy
Room: Cockle Bay 2 - 14:00 - 14:10
Introduction to cryobiopsy
Speaker: Jonathan Williamson, AU - 14:10 - 14:20
Cryobiopsy for central endobronchial lesions
Speaker: Alvin Ing, AU - 14:20 - 14:30
Radial EBUS guided cryobiopsy for peripheral lesions
Speaker: Taj Saghaie, AU - 14:30 - 15:00
Cryobiopsy in ILD
Speaker: Venerino Poletti, Italy - 15:00 - 15:30
Cryobiopsy for pleural pathology
Speaker: Martin Phillips, AU
- 14:00 - 15:30
Pulmonary Circulation: Current topics in mechanisms and treatment for pulmonary hypertension
Room: Cockle Bay 1Current status of diagnosis and treatment for PAH in Japan
Speaker: Yuichi Tamura, JapanPresent status and issues for treating PH associated with respiratory diseases
Speaker: Yoshiteru Morio, JapanMolecular mechanisms and novel treatment strategies for PAH
Speaker: Rebecca Harper, AU
Respiratory Infections (Non-TB) 2: Microbiome
Room: Darling Harbour Theatre- 14:00 - 14:30
What is the microbiome and how is it assessed?
Speaker: Phil Hansbro, AU - 14:30 - 15:00
Dietary metabolites and novel GPCRs for asthma pathogenesis
Speaker: Charles Mackay, Australia - 15:00 - 15:30
Prediction of asthma and COPD using blood microbiome analysis
Speaker: Yoon Keun Kim, Republic of Korea
- 14:00 - 14:30
Oral Presentations: Asthma 3
Room: E3.10- 14:00 - 14:15
Identifying a novel therapeutic strategy for asthma: Targeting airway epithelial cell restitution
Speaker: Thomas Iosifidis, AU - 14:15 - 14:25
A Novel Peptide from the Liver Fluke Fasciola Hepatica Inhibits the Mixed Granulocytic Airway Inflammation in a Mouse Model of Allergic Asthma
Speaker: Venkata Sita Rama Raju Allam, AU - 14:25 - 14:35
The Role of Mitochondrial Fusion in the Pathogenesis of Severe Asthma with Fungal Sensitization
Speaker: So Ri Kim, Republic of Korea - 14:35 - 14:45
Airway Epithelial Phosphoinositide 3-Kinase Delta Contributes to the Modulation of Fungi-Induced Innate Immune Response
Speaker: Yong Chul Lee, Republic of Korea - 14:45 - 14:55
House Dust Mite Directly Induces Free Radical Production and DNA Damage, and Weakens Antioxidant Defense in Human Bronchial Epithelial Cells
Speaker: Wai Shiu Fred Wong, Singapore - 14:55 - 15:05
Efferocytosis of Apoptotic Granulocytes by Monocyte-Derived Macrophages in Adults with Asthma
Speaker: Melanie Erriah, AU - 15:05 - 15:15
Tweak and TGF-B Induced Chemokine Production in Human Bronchial Epithelial Cells During Epithelial Mesenchymal Transition
Speaker: Kei Matsuno, Japan - 15:15 - 15:25
Identification of Novel Genetic Regulations of Asthmatic Airway Epithelium, using Next-Generation Sequencing Data and Bioinformatics Approaches
Speaker: Chau-Chyun Sheu, Taiwan
- 14:00 - 14:15
Oral Presentations: COPD 4
Room: E3.1- 14:00 - 14:10
The Prevalence of Reduced TLCO and the Emphysema Index in Smokers with Normal Spirometry
Speaker: Timothy Cheung, AU - 14:10 - 14:20
Spirometric Indices do not Detect Mismatch between Ventilation and Perfusion in COPD
Speaker: Marika Bajc, Sweden - 14:20 - 14:30
Muscle Echo Intensity Correlates with Physical Activity in Patients with Stable COPD
Speaker: Kazuki Okura, Japan - 14:30 - 14:40
Study of Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease
Speaker: Hiroyuki Ohbayashi, Japan - 14:40 - 14:50
Home-Based Rehabilitation for COPD using Minimal Resources: An Economic Evaluation
Speaker: Angela Burge, AU - 14:50 - 15:00
Increasing Light Physical Activity and Decreasing Sedentary Time in People With Chronic Obstructive Pulmonary Disease - a Preliminary Study
Speaker: Janet Larson, US - 15:00 - 15:10
Quantitative Evaluation of a Novel Self-Management Education Program for COPD in the Context of Multi-Morbidity
Speaker: Sameera Ansari, AU - 15:10 - 15:20
Do Australian Community Pharmacists have a Role in COPD Case Finding?
Speaker: Mariam Fathima, AU
- 14:00 - 14:10
Oral Presentations: Interstitial Lung Disease 2
Room: E3.4- 14:00 - 14:10
Clinicopathological Characteristics of Pulmonary-Limited Vasculitis
Speaker: Sakae Homma, Japan - 14:10 - 14:20
Increased Concentration of B Cell Activating Factors in the Patients with Autoimmune Pulmonary Alveolar Proteinosis
Speaker: Masaki Hirose, Japan - 14:20 - 14:30
Serum Levels of Anti-GM-CSF Autoantibody Reflected Disease Severity of Autoimmune Pulmonary Alveolar Proteinosis Followed up for Long-Term
Speaker: Akiko Matsumuro, Japan - 14:30 - 14:40
Evaluation for the Therapeutic Response by using a Quantitative Computed Tomographic Method in Pulmonary Alveolar Proteinosis
Speaker: Miku Oda, Japan - 14:40 - 14:50
The Diagnosis of Idiopathic Interstitial Pneumonias in a Real World; Nationwide Surveilance in Japan
Speaker: Yoshikazu Inoue, Japan - 14:50 - 15:05
Long-term clinical course of unclassifiable idiopathic interstitial pneumonia diagnosed by surgical lung biopsy
Speaker: Erina Tabata, Japan - 15:05 - 15:15
Chloromethylisothiazolinone and Methylisothiazoline Induces Lung Epithelial Cell Damage and Inflammatory Responses in Mouse Lung
Speaker: Jooyeon Lee, Republic of Korea - 15:15 - 15:25
MUC4 Variable Number Tandem Repeat Polymorphisms and Severe Lung Injury
Speaker: Jun Shiihara, Japan
- 14:00 - 14:10
- 15:30 - 16:00
Plenary Session: Closing Ceremony
Room: Darling Harbour Theatre
